Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CDC25A | P30304 | 7/20 | 0.35 |
| ▸ | CDC25B | P30305 | 7/20 | 0.35 |
| ▸ | CDC25C | P30307 | 6/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.32 |
| ▸ | MPEG1 | Q2M385 | 7/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.32 |
| ▸ | XIAP | P98170 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20464776 | 0.96 | CA9 (0.32) | ALDH1A1MAPTTDP1THRBCDC25A | |
| SCHEMBL4276744 | 0.91 | CA9 (0.32) | CA9 | |
| SCHEMBL4278003 | 0.83 | ALDH1A1 (0.41) | ALDH1A1MAPTTDP1THRBCDC25A | |
| SCHEMBL20172022 | 0.69 | ALDH1A1 (0.32) | ALDH1A1MAPTTDP1THRBCDC25A | |
| SCHEMBL18411940 | 0.68 | ALDH1A1 (0.31) | ALDH1A1MAPTTDP1THRBCDC25A | |
| SCHEMBL3263923 | 0.68 | CA9 (0.49) | MAPTALOX5GPR84KMT2ACA9 | |
| SCHEMBL4276667 | 0.67 | CA9 (0.42) | CA9 | |
| SCHEMBL3189079 | 0.67 | CA9 (0.38) | CA9 | |
| SCHEMBL16638852 | 0.67 | CDC25A (0.33) | ALDH1A1MAPTTDP1THRBCDC25A | |
| SCHEMBL505901 | 0.66 | ALDH1A1 (0.46) | ALDH1A1MAPTTDP1THRBCDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AVENT, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-10251392-B2 | Antimicrobial devices and compositions | AVENT, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| EP-2859961-A2 | Methods and compositions for metal nanoparticle treated surfaces | Avent, Inc. (US) | 2015-04-15 | — | — | EP | disclosed |
| EP-1991365-B1 | METHODS FOR FORMING SILVER-NANOPARTICLE TREATED SURFACES | KIMBERLY CLARK CO (US) | 2014-12-24 | — | — | EP | disclosed |
| US-20130122321-A1 | Methods and Compositions for Metal Nanoparticle Treated Surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130122321-A1 | Methods and Compositions for Metal Nanoparticle Treated Surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130122321-A1 | Methods and Compositions for Metal Nanoparticle Treated Surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-8361553-B2 | Methods and compositions for metal nanoparticle treated surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8361553-B2 | Methods and compositions for metal nanoparticle treated surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8361553-B2 | Methods and compositions for metal nanoparticle treated surfaces | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AVANOS MEDICAL SALES, LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AVANOS MEDICAL SALES, LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AVANOS MEDICAL SALES, LLC | 2009-02-05 | — | — | US | disclosed |
| US-20070207335-A1 | Methods and compositions for metal nanoparticle treated surfaces | AVANOS MEDICAL SALES, LLC | 2007-09-06 | — | — | US | disclosed |
| US-20070207335-A1 | Methods and compositions for metal nanoparticle treated surfaces | AVANOS MEDICAL SALES, LLC | 2007-09-06 | — | — | US | disclosed |
| US-20070207335-A1 | Methods and compositions for metal nanoparticle treated surfaces | AVANOS MEDICAL SALES, LLC | 2007-09-06 | — | — | US | disclosed |
| WO-2007095058-A2 | METHODS AND COMPOSITIONS FOR METAL NANOPARTICLE TREATED SURFACES | ACRYMED, INC. (US) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AAAS, AOC1, COL14A1 | ALDH1A1 178/4885MAPT 2314/4885TDP1 4268/4885 |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AAAS, AOC1, COL14A1 | ALDH1A1 178/4885MAPT 2314/4885TDP1 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.